These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23532410)

  • 41. Didemnins, tamandarins and related natural products.
    Lee J; Currano JN; Carroll PJ; Joullié MM
    Nat Prod Rep; 2012 Mar; 29(3):404-24. PubMed ID: 22270031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo and in silico screening for antimicrobial compounds from cyanobacteria.
    Strieth D; Lenz S; Ulber R
    Microbiologyopen; 2022 Apr; 11(2):e1268. PubMed ID: 35478288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rediscovering cyanobacteria as valuable sources of bioactive compounds.
    Prasanna R; Sood A; Jaiswal P; Nayak S; Gupta V; Chaudhary V; Joshi M; Natarajan C
    Prikl Biokhim Mikrobiol; 2010; 46(2):133-47. PubMed ID: 20391755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural products from cyanobacteria: Exploiting a new source for drug discovery.
    Sielaff H; Christiansen G; Schwecke T
    IDrugs; 2006 Feb; 9(2):119-27. PubMed ID: 16523402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxicity in L929 fibroblasts and inhibition of herpes simplex virus type 1 Kupka by estuarine cyanobacteria extracts.
    Lopes VR; Schmidtke M; Helena Fernandes M; Martins R; Vasconcelos V
    Toxicol In Vitro; 2011 Jun; 25(4):944-50. PubMed ID: 21396440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-infective Natural Products from Cyanobacteria.
    Niedermeyer TH
    Planta Med; 2015 Oct; 81(15):1309-25. PubMed ID: 26085049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemically engineered extracts: source of bioactive compounds.
    Ramallo IA; Salazar MO; Mendez L; Furlan RL
    Acc Chem Res; 2011 Apr; 44(4):241-50. PubMed ID: 21355557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mini-review: Inhibition of biofouling by marine microorganisms.
    Dobretsov S; Abed RM; Teplitski M
    Biofouling; 2013; 29(4):423-41. PubMed ID: 23574279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current approaches to discover marine antileishmanial natural products.
    Tempone AG; Martins de Oliveira C; Berlinck RG
    Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemical interference of biological systems with natural products.
    Gademann K; Sieber S
    Chimia (Aarau); 2011; 65(11):835-8. PubMed ID: 22289366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-ribosomal peptides produced by Brazilian cyanobacterial isolates with antimicrobial activity.
    Silva-Stenico ME; Silva CS; Lorenzi AS; Shishido TK; Etchegaray A; Lira SP; Moraes LA; Fiore MF
    Microbiol Res; 2011 Mar; 166(3):161-75. PubMed ID: 20630723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Jewel of the seabed: sea cucumbers as nutritional and drug candidates.
    Kiew PL; Don MM
    Int J Food Sci Nutr; 2012 Aug; 63(5):616-36. PubMed ID: 22149726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Confronting the challenges of natural product-based antifungal discovery.
    Roemer T; Xu D; Singh SB; Parish CA; Harris G; Wang H; Davies JE; Bills GF
    Chem Biol; 2011 Feb; 18(2):148-64. PubMed ID: 21338914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marine actinomycetes: an ongoing source of novel bioactive metabolites.
    Subramani R; Aalbersberg W
    Microbiol Res; 2012 Dec; 167(10):571-80. PubMed ID: 22796410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SAR analysis and bioactive potentials of freshwater and terrestrial cyanobacterial compounds: a review.
    Nagarajan M; Maruthanayagam V; Sundararaman M
    J Appl Toxicol; 2013 May; 33(5):313-49. PubMed ID: 23172644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyanobacteria as a Source for Novel Anti-Leukemic Compounds.
    Humisto A; Herfindal L; Jokela J; Karkman A; Bjørnstad R; Choudhury RR; Sivonen K
    Curr Pharm Biotechnol; 2016; 17(1):78-91. PubMed ID: 26306745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical review of actually available chemical compounds for prevention and management of cyanobacterial blooms.
    Jančula D; Maršálek B
    Chemosphere; 2011 Nov; 85(9):1415-22. PubMed ID: 21925702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ion mobility mass spectrometry enables the efficient detection and identification of halogenated natural products from cyanobacteria with minimal sample preparation.
    Esquenazi E; Daly M; Bahrainwala T; Gerwick WH; Dorrestein PC
    Bioorg Med Chem; 2011 Nov; 19(22):6639-44. PubMed ID: 21784647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of cyanobacterial metabolites as natural medical and biotechnological tools: review article.
    Saad MH; El-Fakharany EM; Salem MS; Sidkey NM
    J Biomol Struct Dyn; 2022 Apr; 40(6):2828-2850. PubMed ID: 33164673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics.
    Ferreira L; Morais J; Preto M; Silva R; Urbatzka R; Vasconcelos V; Reis M
    Mar Drugs; 2021 Nov; 19(11):. PubMed ID: 34822504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.